Target intelligence / Profile preview

Paracellular pathway

Molecular classification
Other
01

Overview

Paracellular pathway refers to the route by which water, ions, and other small molecules pass *between* cells, specifically through the spaces sealed by tight junctions in epithelial or endothelial barriers, rather than through the cells themselves[1][3][5]. Unlike molecular targets such as receptors or transporters, the paracellular pathway is a structural feature regulated by tight junction proteins (including claudins, occludin, tricellulin, and others) that confer selectivity based on size and charge[2][3][6]. This pathway is primarily passive and does not involve saturable or energy-dependent transport—it relies on existing chemical and electrochemical gradients[1][3][5]. Under normal physiological conditions, the paracellular pathway plays a minor role in solute absorption in most mammals, with exceptions in some species (e.g., small birds and bats). It is significantly implicated in pathological contexts: disruption of tight junctions increases paracellular permeability, which is a mechanism in certain gastrointestinal diseases, infections, and can be targeted by some bacterial toxins, resulting in diarrhea and compromised barrier function[2][3][6]. Its function is also important for the oral bioavailability of certain hydrophilic drugs, though only a few drugs primarily use this route, often with low efficiency[1]. Because the paracellular pathway is not a molecular entity and does not fit the definition of a specific "therapeutic target," it is considered incorrect to list it as a drug target[1][5].

Other names
Paracellular transport
02

Biological functions

Epithelial barrier functionPassive transport of ions, solutes, and waterMaintenance of tissue homeostasisDrug absorption (minor)
03

Disease associations

Inflammatory bowel diseaseInfections (e.g., bacterial/viral disruption)Diarrhea (via barrier dysfunction)Renal diseases (proximal tubule dysfunction)Ischemic injury (renal, intestinal)
04

Safety considerations

Non-specific molecular passage during barrier disruption increases infection and inflammatory riskBarrier dysfunction leads to fluid/electrolyte imbalances
05

Biomarkers

Mannitol and lactulose recovery in urine (test for intestinal permeability)

Beyond the preview

Go deeper on Paracellular pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracellular pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call